[Recommendations for the treatment of bancroftian filariasis in symptomless and diseased patients].
Identifieur interne : 000888 ( Ncbi/Merge ); précédent : 000887; suivant : 000889[Recommendations for the treatment of bancroftian filariasis in symptomless and diseased patients].
Auteurs : Gerusa Dreyer [Brésil] ; Patrícia Dreyer ; Joaquim NoroesSource :
- Revista da Sociedade Brasileira de Medicina Tropical [ 0037-8682 ]
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- therapy : Elephantiasis, Filarial.
- Animals, Humans, Wuchereria bancrofti.
Abstract
The goals of treatment for lymphatic filariasis are: to prevent, reverse, or halt progression of disease; and to interrupt transmission of the parasite. Selecting the appropriate therapy for the patient with lymphatic filariasis requires knowledge of the various clinical features of filarial disease and their pathogenesis. In the past, treatment of lymphatic filariasis has focused primarily on antiparasitic chemotherapy; however, for many of the acute and chronic manifestations of lymphatic filariasis, it is now clear that supportive or other forms of clinical care are even more important than antiparasitic medication in order to prevent worsening of the disease. Regardless of the clinical manifestations of filarial disease in a particular patient, the following three components of treatment should, in general, be considered: supportive or disease specific clinical care (including hygiene and diet), patient education and counseling and finally, antiparasitic chemotherapy with diethylcarbamazine (DEC) and/or the combination of DEC with ivermectin. The authors also describe the proportional efficacy of diethylcarbamazine and ivermectin, alone or in combination, for use in mass treatment aiming at transmission interruption and the use of hygiene as a public health approach for lymphedema prevention.
PubMed: 11873261
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004645
- to stream PubMed, to step Curation: 004645
- to stream PubMed, to step Checkpoint: 004645
Links to Exploration step
pubmed:11873261Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Recommendations for the treatment of bancroftian filariasis in symptomless and diseased patients].</title><author><name sortKey="Dreyer, Gerusa" sort="Dreyer, Gerusa" uniqKey="Dreyer G" first="Gerusa" last="Dreyer">Gerusa Dreyer</name><affiliation wicri:level="1"><nlm:affiliation>Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Brasil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Recife</wicri:regionArea><wicri:noRegion>Recife</wicri:noRegion></affiliation></author><author><name sortKey="Dreyer, Patricia" sort="Dreyer, Patricia" uniqKey="Dreyer P" first="Patrícia" last="Dreyer">Patrícia Dreyer</name></author><author><name sortKey="Noroes, Joaquim" sort="Noroes, Joaquim" uniqKey="Noroes J" first="Joaquim" last="Noroes">Joaquim Noroes</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2002 Jan-Feb</MedlineDate></PubDate></date><idno type="RBID">pubmed:11873261</idno><idno type="pmid">11873261</idno><idno type="wicri:Area/PubMed/Corpus">004645</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004645</idno><idno type="wicri:Area/PubMed/Curation">004645</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004645</idno><idno type="wicri:Area/PubMed/Checkpoint">004645</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004645</idno><idno type="wicri:Area/Ncbi/Merge">000888</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Recommendations for the treatment of bancroftian filariasis in symptomless and diseased patients].</title><author><name sortKey="Dreyer, Gerusa" sort="Dreyer, Gerusa" uniqKey="Dreyer G" first="Gerusa" last="Dreyer">Gerusa Dreyer</name><affiliation wicri:level="1"><nlm:affiliation>Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Brasil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Recife</wicri:regionArea><wicri:noRegion>Recife</wicri:noRegion></affiliation></author><author><name sortKey="Dreyer, Patricia" sort="Dreyer, Patricia" uniqKey="Dreyer P" first="Patrícia" last="Dreyer">Patrícia Dreyer</name></author><author><name sortKey="Noroes, Joaquim" sort="Noroes, Joaquim" uniqKey="Noroes J" first="Joaquim" last="Noroes">Joaquim Noroes</name></author></analytic><series><title level="j">Revista da Sociedade Brasileira de Medicina Tropical</title><idno type="ISSN">0037-8682</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Elephantiasis, Filarial (therapy)</term><term>Humans</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Filariose lymphatique ()</term><term>Humains</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Filariose lymphatique</term><term>Humains</term><term>Wuchereria bancrofti</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The goals of treatment for lymphatic filariasis are: to prevent, reverse, or halt progression of disease; and to interrupt transmission of the parasite. Selecting the appropriate therapy for the patient with lymphatic filariasis requires knowledge of the various clinical features of filarial disease and their pathogenesis. In the past, treatment of lymphatic filariasis has focused primarily on antiparasitic chemotherapy; however, for many of the acute and chronic manifestations of lymphatic filariasis, it is now clear that supportive or other forms of clinical care are even more important than antiparasitic medication in order to prevent worsening of the disease. Regardless of the clinical manifestations of filarial disease in a particular patient, the following three components of treatment should, in general, be considered: supportive or disease specific clinical care (including hygiene and diet), patient education and counseling and finally, antiparasitic chemotherapy with diethylcarbamazine (DEC) and/or the combination of DEC with ivermectin. The authors also describe the proportional efficacy of diethylcarbamazine and ivermectin, alone or in combination, for use in mass treatment aiming at transmission interruption and the use of hygiene as a public health approach for lymphedema prevention.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11873261</PMID><DateCreated><Year>2002</Year><Month>03</Month><Day>01</Day></DateCreated><DateCompleted><Year>2002</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0037-8682</ISSN><JournalIssue CitedMedium="Print"><Volume>35</Volume><Issue>1</Issue><PubDate><MedlineDate>2002 Jan-Feb</MedlineDate></PubDate></JournalIssue><Title>Revista da Sociedade Brasileira de Medicina Tropical</Title><ISOAbbreviation>Rev. Soc. Bras. Med. Trop.</ISOAbbreviation></Journal><ArticleTitle>[Recommendations for the treatment of bancroftian filariasis in symptomless and diseased patients].</ArticleTitle><Pagination><MedlinePgn>43-50</MedlinePgn></Pagination><Abstract><AbstractText>The goals of treatment for lymphatic filariasis are: to prevent, reverse, or halt progression of disease; and to interrupt transmission of the parasite. Selecting the appropriate therapy for the patient with lymphatic filariasis requires knowledge of the various clinical features of filarial disease and their pathogenesis. In the past, treatment of lymphatic filariasis has focused primarily on antiparasitic chemotherapy; however, for many of the acute and chronic manifestations of lymphatic filariasis, it is now clear that supportive or other forms of clinical care are even more important than antiparasitic medication in order to prevent worsening of the disease. Regardless of the clinical manifestations of filarial disease in a particular patient, the following three components of treatment should, in general, be considered: supportive or disease specific clinical care (including hygiene and diet), patient education and counseling and finally, antiparasitic chemotherapy with diethylcarbamazine (DEC) and/or the combination of DEC with ivermectin. The authors also describe the proportional efficacy of diethylcarbamazine and ivermectin, alone or in combination, for use in mass treatment aiming at transmission interruption and the use of hygiene as a public health approach for lymphedema prevention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dreyer</LastName><ForeName>Gerusa</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dreyer</LastName><ForeName>Patrícia</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Noroes</LastName><ForeName>Joaquim</ForeName><Initials>J</Initials></Author></AuthorList><Language>por</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Recomendações para o tratamento da filariose bancroftiana, na infecção e na doença.</VernacularTitle></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Rev Soc Bras Med Trop</MedlineTA><NlmUniqueID>7507456</NlmUniqueID><ISSNLinking>0037-8682</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014958" MajorTopicYN="Y">Wuchereria bancrofti</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>64</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>3</Month><Day>2</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>11</Month><Day>1</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>3</Month><Day>2</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11873261</ArticleId><ArticleId IdType="pii">S0037-86822002000100009</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Brésil</li></country></list><tree><noCountry><name sortKey="Dreyer, Patricia" sort="Dreyer, Patricia" uniqKey="Dreyer P" first="Patrícia" last="Dreyer">Patrícia Dreyer</name><name sortKey="Noroes, Joaquim" sort="Noroes, Joaquim" uniqKey="Noroes J" first="Joaquim" last="Noroes">Joaquim Noroes</name></noCountry><country name="Brésil"><noRegion><name sortKey="Dreyer, Gerusa" sort="Dreyer, Gerusa" uniqKey="Dreyer G" first="Gerusa" last="Dreyer">Gerusa Dreyer</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000888 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000888 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:11873261
|texte= [Recommendations for the treatment of bancroftian filariasis in symptomless and diseased patients].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:11873261" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |